University Cancer Research Fund

The University Cancer Research Fund (UCRF) is a nation-leading investment to stimulate cancer research and reduce North Carolina's leading cause of death. The Fund builds upon the exceptional research base at UNC Lineberger Comprehensive Cancer Center, the state's only public, NCI-designated comprehensive cancer center.

UCRF's Goal

To create a nation-leading cancer research effort and to reduce North Carolina's cancer burden. UCRF is accomplishing these goals through:

  • Discovery to better understand the causes and course of cancer;
  • Innovation to create new and better ways to prevent, diagnose and treat cancer; and by stimulating
  • Delivery of improved cancer care, screening and prevention across the state.

Latest News

Timing could matter to how responsive cancer cells are to treatment, study suggests

Using new knowledge about cell division, researchers look to improve chemotherapy effects

To improve melanoma treatment, researchers look to block deletion of ‘self-reactive’ immune cells

Innovative cancer data resource expands, gains a new name

Study sheds light on why some breast cancers have limited response to immunotherapy

Using ‘sticky’ nanoparticles, researchers develop new strategy to boost body’s cancer defenses

New models of kidney cancer may drive immunotherapy research

UNC-Chapel Hill spinout company generates more than $108M in stock offering

In ovarian cancer, researchers uncover new drivers of cell division

Researchers map genetic changes in glioblastoma as it progresses, test potential treatment strategy

Study confirms link between alcohol consumption, breast cancer risk in black women

Images of health risks make indoor tanning messages more effective

UNC Lineberger receives $4 million gift to support promising new cancer treatment

Aggressive breast cancer grows faster in obese environment

New insights into side effects can help prostate cancer patients choose treatments

UNC Lineberger launches innovative cellular immunotherapy program

Revolutionary approach for treating glioblastoma works with human cells

Researchers unlock mechanism of drug resistance in aggressive breast cancer

Genetic alterations more common in tumors of older patients with metastatic breast cancer

The dark side of ‘junk’ DNA: Repeating DNA sequences play a role in bone cancer

Racial gaps persist in how breast cancer survivors function, feel during treatment and after

Scientists discover interplay of yin-yang antagonists vital for cell division

Researchers use genetics to probe immune system’s role in fighting cancer

Cancer cells continue abnormal growth by activating error-prone DNA synthesis

Insurance, distance to care can be barriers to breast reconstruction